Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.

Hunt AR, Nguyen V, Creuzot-Garcher CP, Alforja S, Gabrielle PH, Zarranz-Ventura J, Guillemin M, Fraser-Bell S, Casaroli Marano RP, Arnold J, McAllister IL, O'Toole L, Gillies MC, Barthelmes D, Mehta H

Open source

DOI: 10.1136/bjophthalmol-2020-318491
Published: 2022 Aug
Container: The British journal of ophthalmology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bjophthalmol-2020-318491,
  title = {Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.},
  author = {Hunt AR and Nguyen V and Creuzot-Garcher CP and Alforja S and Gabrielle PH and Zarranz-Ventura J and Guillemin M and Fraser-Bell S and Casaroli Marano RP and Arnold J and McAllister IL and O'Toole L and Gillies MC and Barthelmes D and Mehta H},
  year = {2022},
  journal = {The British journal of ophthalmology},
  doi = {10.1136/bjophthalmol-2020-318491},
  url = {https://doi.org/10.1136/bjophthalmol-2020-318491}
}

RIS

TY  - JOUR
TI  - Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.
AU  - Hunt AR
AU  - Nguyen V
AU  - Creuzot-Garcher CP
AU  - Alforja S
AU  - Gabrielle PH
AU  - Zarranz-Ventura J
AU  - Guillemin M
AU  - Fraser-Bell S
AU  - Casaroli Marano RP
AU  - Arnold J
AU  - McAllister IL
AU  - O'Toole L
AU  - Gillies MC
AU  - Barthelmes D
AU  - Mehta H
PY  - 2022
JO  - The British journal of ophthalmology
DO  - 10.1136/bjophthalmol-2020-318491
UR  - https://doi.org/10.1136/bjophthalmol-2020-318491
ER  -

APA

AR, H., V, N., CP, C., S, A., PH, G., J, Z., M, G., S, F., RP, C. M., J, A., IL, M., L, O., MC, G., D, B., & H, M. (2022). Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.. The British journal of ophthalmology. https://doi.org/10.1136/bjophthalmol-2020-318491

Source records

pubmed · retrieved 2026-09-26T12:15:08.483Z